Haemonetics Corp (NYSE:HAE)

43.35
Delayed Data
As of Apr 24
 +0.74 / +1.74%
Today’s Change
29.86
Today|||52-Week Range
45.43
+15.85%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Revenue and IncomeNet Revenues241.1M224.5M227.6M231.8M
 
 
 
 
 
Cost of Goods Sold103.9M97.7M98.4M61.1M
 
 
 
 
 
Depreciation And Amortization22.7M20.5M21.1M59.1M
 
 
 
 
 
 
Operating ExpensesGross Income114.5M106.3M108.1M111.7M
 
 
 
 
 
General Expenses85.3M85.0M80.4M80.5M
 
 
 
 
 
Research And Development13.8M15.4M10.9M10.6M
 
 
 
 
 
Total Operating Expenses211.9M203.2M199.8M200.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income29.2M21.3M27.8M31.2M
 
 
 
 
 
Extraordinary Credit0.000.002.8M--
 
 
Extraordinary Charge-16.6M-23.2M-15.3M-12.9M
 
 
 
 
 
Interest Expense On Debt2.9M2.3M5.2M2.3M
 
 
 
 
 
Other Expenses0.00-5.0K-235.0K0.00
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income9.8M-4.2M9.8M16.0M
 
 
 
 
 
Income Taxes-429.0K-560.0K-2.3M-36.0K
 
 
 
 
 
Net Income10.2M-3.6M7.5M16.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS52.0M51.7M51.4M51.4M
 
 
 
 
 
Shares To Calculate EPS Diluted52.6M51.7M51.9M52.0M
 
 
 
 
 
 
Earnings Per ShareEPS$0.19-$0.07$0.14$0.31
 
 
 
 
 
EPS Diluted$0.19-$0.07$0.14$0.31
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account